Oxonol (MGM-15) Tablets: DEA Scheduling Update
Where's Oxonol?
Starting August 25, 2026, the DEA has classified MGM-15 (Oxonol) as a Schedule I controlled substance under the Controlled Substances Act. As a result, we can no longer sell this product.
7-HYDRO IS STILL AVAILABLE!
(But not for long.)
Real Botanicals 7-hydroxymitragynine tablets deliver precision-dosed 7-OH, the celebrated kratom alkaloid known for its potency and fast onset. Each chewable tablet uses our proprietary ChromaPure extraction to isolate 7-hydroxymitragynine at consistent, verifiable concentrations, giving you a controlled way to explore one of kratom's most advanced compounds. Always third-party lab tested for purity and potency.
A little goes a long way. These 7-Hydro tabs come in 10mg, 20mg, and 40mg strengths with splittable scoring for finer serving control, so you can match the product to your experience level. Built for adults who respect botanical strength and want an extract with the spec sheet to back it up.
Flavor
Strength
Size
7-Hydroxymitragynine (7-OH) is a minor alkaloid found in Mitragyna speciosa leaves at low natural concentrations. Through ChromaPure, we isolate and concentrate it into a form that delivers fast onset and long-lasting support at precise serving sizes.
7-Hydro Tablet Facts:
- Each tablet is splittable for finer serving control
- Concentrated 7-OH means smaller, less frequent servings
- Portable, discreet, chewable, no mixing required
- Long-lasting session length
- Peppermint flavor
Available in:
- 10mg strength: 3ct, 10ct, 20ct, 50ct
- 20mg strength: 3ct, 10ct, 20ct, 50ct
- 40mg strength: 3ct, 10ct, 30ct, 50ct
- 100mg strength, 4ct, 10ct, 20ct
7-Hydroxymitragynine (10mg per tablet, 20mg per tablet, 40mg per tablet or 100mg per tablet )
Certified lab testing ensures that your 7-Hydro products are pure, potent, and free from contaminants such as yeast, mold, coliform, salmonella, staphylococcus, E. Coli, and heavy metals.
As with all products, do not exceed dosing recommendations.
This product has not been evaluated by the Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Not for sale to minors. Daily value not established. The FDA has not yet approved this product for human consumption.
CAUTION: Any product that alters how you feel can be habit-forming. If you have addiction issues, do not consume this product. Consult a physician before consuming.
A note for regular Oxonol users
If you've been taking Oxonol daily, stopping suddenly can be uncomfortable. That's worth knowing before the shelf goes empty, and it's worth talking through with a healthcare provider rather than figuring out alone. We'd rather give you good information than pretend this isn't part of the picture. Our guide covers what dependence actually looks like, what to expect, and what options exist — written plainly, no judgment.
What is Oxonol (MGM-15)?
MGM-15 is the compound that made Oxonol work, and it's worth understanding what it actually was — partly because it explains why the ban reached it. Read the complete guide to what is Oxonol here.
Its chemical name is dihydro-7-hydroxymitragynine. Start with mitragynine, the primary alkaloid in the kratom leaf. Oxidize it and you get 7-hydroxymitragynine, or 7-OH. Take 7-OH into a lab and reduce it, and you get MGM-15 — structurally close to 7-OH but modified, more stable, and more predictable at very small serving sizes. That stability is why Oxonol was dosed in 7.5mg and 15mg fractions instead of grams, and why the tablets were split-scored.
Paired with mitragynine, it gave Oxonol the profile people came back for: fast onset, a long level stretch, and a finish without a hard drop.
If you want to go deeper, be sure ot check out our library of additional content:
Oxonol (MGM-15) FAQs
Yes. Dihydro-7-hydroxymitragynine (MGM-15) is one of four compounds named directly in the DEA's Notice of Intent for temporary Schedule I placement. Once the order takes effect, it can't be sold or shipped anywhere in the U.S.
Oxonol was built around state-level 7-OH restrictions, and against those it did have a different footprint. The federal action worked differently — it named a category of concentrated kratom-derived compounds rather than one molecule. MGM-15 is derived from 7-OH, so it was included. We built for the rule we could see, and a broader one arrived.
No. This is a federal scheduling action, so it applies everywhere regardless of state law. Retail partners are pulling stock on the same timeline.
7-OH occurs naturally in kratom leaves in trace amounts. MGM-15 is made from the 7-OH molecule in a lab through a reduction step — more stable and more consistent at small servings, but not something that exists in the plant. Both are covered by the same order.
We can't make promises about future regulatory action, and you should be skeptical of anyone who does — including us, after this. What we can point to is the distinction the DEA actually used. This action covered compounds refined from kratom into forms the plant doesn't produce. ACEND is a kratom extract: the plant's own alkaloid profile, purified and balanced, nothing synthesized. That's a different category from what was scheduled, and it's the most honest basis we can give you.
No. Traditional kratom leaf below the threshold isn't targeted here. State and local laws still vary, so check your local rules. See the latest on kratom legality in the U.S.
Orders placed before the effective date shipped normally. Active subscriptions have been transitioned — your account and email have the details.
It's a temporary order, which can be extended, made permanent, or allowed to lapse. We don't know yet, and we'd rather say so than guess. Get on the MIT-OH list, and we'll keep you current either way!